The Animal Models, Stem Cells and Cell Therapy Core facilitates translational research in the Marion Bessin Liver Research Center by providing unique resources, technologies and scientific expertise at cost savings. The Core was reorganized since previous the Center renewal, preserving all previous services and including additional services in response to the evolving needs of Center Investigators. The Core has accumulated extensive expertise in cutting-edge technologies and resources for studies using various liver cell types, including stem cells, as well as unique animal models. This benefits Center Investigators pursuing basic studies of pathophysiological mechanisms or cell and gene therapy. For instance, exciting opportunities are generated for Center Investigators through expertise in disease models, distribution of high quality cell preparations, which were instrumental for novel therapeutic developments in metabolic deficiency states, genetic diseases, radiation injury and acute or chronic liver failure. Simultaneously, numerous studies were advanced in hepatic gene expression, stem/progenitor cell biology, inflammation, autophagy, liver growth control, pathophysiological mechanisms of liver transport. Similarly, educational activities position the Core as an important resource.
The Aims of this Core are as follows: To breed, maintain and provide animals that are not readily available from other sources, """""""" To develop or reproduce relevant induced animal models. To isolate and distribute high quality primary animal or human liver cells, """""""" To provide liver cells generated from pluripotent stem cells using highly efficient protocols, """""""" To instruct investigators in stem cell methods and commonly used animal procedures, """""""" To offer consultation for experimental design for animal studies To provide optimized, cost-effective liver cell culture conditions and additives, """""""" To incorporate new technologies for animal and human stem cell and cell therapy studies, """""""" To encourage use of the Core by early-stage investigators or investigators new to liver research.
The Animal Models, Stem Cells and Cell Therapy Core facilitates generation of novel insights into disease mechanisms and development of novel diagnostic tools and therapies. The range of liver diseases reaping benefits from these resources is broad and includes metabolic diseases and viral hepatitis, which afflict millions of people as well as orphan diseases (e.g., Wilson disease), which also merit attention.
|Soltys, Kyle A; Setoyama, Kentaro; Tafaleng, Edgar N et al. (2017) Host conditioning and rejection monitoring in hepatocyte transplantation in humans. J Hepatol 66:987-1000|
|Jaber, Fadi Luc; Sharma, Yogeshwar; Gupta, Sanjeev (2017) Demonstrating Potential of Cell Therapy for Wilson's Disease with the Long-Evans Cinnamon Rat Model. Methods Mol Biol 1506:161-178|
|Wijetunga, N A; Pascual, M; Tozour, J et al. (2017) A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets. Oncogene 36:2030-2044|
|Roy-Chowdhury, Jayanta; Roy-Chowdhury, Namita; Listowsky, Irving et al. (2017) Drug- and Drug Abuse-Associated Hyperbilirubinemia: Experience With Atazanavir. Clin Pharmacol Drug Dev 6:140-146|
|Akiyama, Matthew J; Kaba, Fatos; Rosner, Zachary et al. (2017) Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System. Public Health Rep 132:41-47|
|Shen, Ling; Wang, David Q H; Xu, Meifeng et al. (2017) BDNF/TrkB signaling mediates the anorectic action of estradiol in the nucleus tractus solitarius. Oncotarget 8:84028-84038|
|Arvans, Donna; Jung, Yong-Chul; Antonopoulos, Dionysios et al. (2017) Oxalobacter formigenes-Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells. J Am Soc Nephrol 28:876-887|
|Zhao, H; Lu, Z; Bauzon, F et al. (2017) p27T187A knockin identifies Skp2/Cks1 pocket inhibitors for advanced prostate cancer. Oncogene 36:60-70|
|Rogler, Charles E; Bebawee, Remon; Matarlo, Joe et al. (2017) Triple Staining Including FOXA2 Identifies Stem Cell Lineages Undergoing Hepatic and Biliary Differentiation in Cirrhotic Human Liver. J Histochem Cytochem 65:33-46|
|Maus, Mate; Cuk, Mario; Patel, Bindi et al. (2017) Store-Operated Ca2+ Entry Controls Induction of Lipolysis and the Transcriptional Reprogramming to Lipid Metabolism. Cell Metab 25:698-712|
Showing the most recent 10 out of 399 publications